Methodological considerations for interpretation of rates of major haemorrhage in studies of anticoagulant therapy for atrial fibrillation

Europace. 2008 Jan;10(1):3-5. doi: 10.1093/europace/eum258. Epub 2007 Nov 26.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use*
  • Aspirin / adverse effects
  • Aspirin / therapeutic use
  • Atrial Fibrillation / complications*
  • Bias
  • Humans
  • Intracranial Hemorrhages / chemically induced*
  • Randomized Controlled Trials as Topic
  • Risk Factors
  • Stroke / etiology*
  • Stroke / prevention & control*
  • Warfarin / adverse effects
  • Warfarin / therapeutic use

Substances

  • Anticoagulants
  • Warfarin
  • Aspirin